July 12, 2022
3 min watch
Save
VIDEO: Improvement in Schirmer test score observed with Tyrvaya treatment
WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, James A. Katz, MD, discusses dry eye research that focuses on a patient’s overall well-being rather than just one eye.
Katz said that for a patient to feel better overall, both eyes should be treated. In a study with nearly 900 participants, Tyrvaya (varenicline solution, Oyster Point Pharma) showed significant improvement in mean Schirmer test score as well as clinically significant improvement in the fellow eye.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Katz reports no relevant financial disclosures.
Read more about